Table 5

Multisite kinetic model interaction factors to describe the various modifications of CYP3A4 activity

Effect on CYP3A4Interaction FactorExample
αγ5-150δ
Activation, S showing hyperbolic kinetics1>1<1QUI effect on FEL, SV
QUI effect on diclofenac5-a, warfarinb
Inhibition, S showing hyperbolic kinetics1<1<1HAL effect on FEL, QUIc
Inhibition, S showing substrate inhibition1<1<1QUI, HAL effect on NIF
(β < 1, could = γ)MDZ, FEL effect on NIFc
Partial inhibition, S showing hyperbolic kinetics11>1NIF effect on FELc
TST-MDZc e, TST-erythromycind, TST-Terfenadinee
Partial inhibition, S showing sigmoidal kinetics5-g <11>1HAL effect on TST
Heterotropic activation, S showing sigmoidal kinetics5-g <1>1TST effect on DZf
Heterotropic inhibition, S showing sigmoidal kinetics5-g <11≤1QUI effect on TST, DZ effect on TSTf
  • 5-150  β (changes in Kp from SES) = 2 (equivalent binding sites).

  • 5-a Ngui et al. (2000); bNgui et al. (2001);cA. Galetin, unpublished data; dWang et al., 1997;eWang et al., 2000; fKenworthy et al., 2000.

  • 5-g Three-site model.